{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:32:59Z","timestamp":1786361579478,"version":"build-2736575974"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The gut-heart axis is a new therapeutic target for cardiovascular diseases, which continue to be the leading cause of death worldwide. Metabolites originating from microorganisms have demonstrated significant impacts on inflammation, remodeling, and heart function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>By assessing molecular pathways, therapeutic options, and translational barriers, this narrative review seeks to objectively examine the cardioprotective potential of gut microbial metabolites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We reviewed and summarized the most recent research on the impact of microbial metabolites, both beneficial and detrimental, on endothelium repair, fibrosis, immunometabolism, and cardiac bioenergetics. A systematic search was conducted using the phrases \u201cgut-heart axis,\u201d \u201cmicrobial metabolites,\u201d and \u201ccardiovascular protection\u201d in PubMed, Scopus, and Web of Science for the years 2018\u20132024. Preclinical and clinical research that met the eligibility requirements were vetted and narratively synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>By modulating Nrf2, HDAC, and TGF-\u03b2\/Smad, protective metabolites such as short-chain fatty acids, urolithins, and indoles have anti-inflammatory, anti-fibrotic, and mitochondrial-enhancing properties. On the other hand, oxidative stress and fibrosis are made worse by trimethylamine N-oxide and hydrogen sulfide. Postbiotic formulations, innovative delivery systems, and synthetic biology provide promising approaches for focused intervention. However, there are substantial translational obstacles due to pharmacokinetic, regulatory, and microbiota heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Microbial metabolites produced in the gut are a promising and revolutionary class of cardioprotectants. Future cardiovascular treatments may be redefined by precision-targeted gut-heart axis modulation, although clinical validation and regulatory standardization are still crucial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004529","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:01:43Z","timestamp":1766059303000},"page":"1511-1520","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["\u201cMicrobial metabolites in cardioprotection: an immune-engineered framework for heart failure and post-ischemic remodeling: a narrative review\u201d"],"prefix":"10.1097","volume":"88","author":[{"given":"Asra","family":"Amjad","sequence":"first","affiliation":[{"name":"Islamic International Medical College, Rawalpindi Pakistan (Riphah International University), Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Azam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Medical and Dental College Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadiha","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gajju Khan Medical College, Swabi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Swabi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Altaf","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karachi Metropolitan University, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0717-2777","authenticated-orcid":false,"given":"Muddassir","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Rizwan","family":"Javed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"R1-20260810","doi-asserted-by":"crossref","first-page":"1067\u201385","DOI":"10.1080\/13543784.2022.2113375","article-title":"Investigational drugs in clinical trials for macular degeneration","volume":"31","author":"Tolentino","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"key":"R2-20260810","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.3390\/ijms252212465","article-title":"The Gut\u2013Heart axis: molecular perspectives and implications for myocardial infarction","volume":"25","author":"Rivera","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R3-20260810","doi-asserted-by":"crossref","first-page":"113394","DOI":"10.1016\/j.intimp.2024.113394","article-title":"Urolithin A improves myocardial ischemia\u2013reperfusion injury by attenuating oxidative stress and ferroptosis through the Nrf2 pathway","volume":"143","author":"Su","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R4-20260810","article-title":"The role of inflammatory response in the development of atherosclerosis, myocardial infarction, and remodeling","volume":"8","author":"Botros","year":"2024","journal-title":"Vessel Plus"},{"key":"R5-20260810","article-title":"Re-defining the gut heart axis: a systematic review of the literature on the role of gut microbial dysbiosis in patients with heart failure","volume":"15","author":"Desai","year":"2023","journal-title":"Cureus"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"108\u201313","DOI":"10.29328\/journal.jccm.1001162","article-title":"Faecal transplant therapy: a promising treatment modality for cardiovascular diseases","volume":"8","author":"Pushkala","year":"2023","journal-title":"J Cardiol Cardiovasc Med"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"2089\u2013105","DOI":"10.1016\/j.jacc.2019.03.024","article-title":"Intestinal microbiota in cardiovascular health and disease","volume":"73","author":"Tang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R9-20260810","doi-asserted-by":"crossref","first-page":"1165\u201399","DOI":"10.1089\/ars.2020.8040","article-title":"Epigenetic remodeling in obesity-related vascular disease","volume":"34","author":"Masi","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"R10-20260810","article-title":"Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"R11-20260810","doi-asserted-by":"crossref","first-page":"104655","DOI":"10.1016\/j.phrs.2020.104655","article-title":"Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia\/reperfusion injury via p62\/Keap1\/Nrf2 signaling pathway","volume":"153","author":"Zheng","year":"2020","journal-title":"Pharmacol Res"},{"key":"R12-20260810","doi-asserted-by":"crossref","first-page":"1223349","DOI":"10.3389\/fnut.2023.1223349","article-title":"Ginger: a representative material of herb-derived exosome-like nanoparticles","volume":"10","author":"Zhu","year":"2023","journal-title":"Front Nutr"},{"key":"R13-20260810","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/antibiotics13050392","article-title":"The role of gut microbiota in the etiopathogenesis of multiple chronic diseases","volume":"13","author":"Pires","year":"2024","journal-title":"Antibiotics"},{"key":"R14-20260810","doi-asserted-by":"crossref","first-page":"pbad005","DOI":"10.1093\/pcmedi\/pbad005","article-title":"Circulating metabolic signatures of heart failure in precision cardiology","volume":"6","author":"Xie","year":"2023","journal-title":"Precis Clin Med"},{"key":"R15-20260810","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/biomedicines11102712","article-title":"The modulation effect of a fermented bee pollen postbiotic on cardiovascular microbiota and therapeutic perspectives","volume":"11","author":"Dinu","year":"2023","journal-title":"Biomedicines"},{"key":"R16-20260810","doi-asserted-by":"crossref","first-page":"1087\u201397","DOI":"10.1080\/17460441.2023.2239704","article-title":"Bacterial synthetic biology: tools for novel drug discovery","volume":"18","author":"Wang","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"R17-20260810","doi-asserted-by":"crossref","first-page":"1059349","DOI":"10.3389\/fcimb.2022.1059349","article-title":"Update on gut microbiota in cardiovascular diseases","volume":"12","author":"Qian","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R18-20260810","doi-asserted-by":"crossref","first-page":"1392666","DOI":"10.3389\/fnut.2024.1392666","article-title":"Obesity-associated inflammation countered by a Mediterranean diet: the role of gut-derived metabolites","volume":"11","author":"Florkowski","year":"2024","journal-title":"Front Nutr"},{"key":"R19-20260810","doi-asserted-by":"crossref","first-page":"397\u2013422","DOI":"10.1146\/annurev-virology-040323-082822","article-title":"Regulation of immune homeostasis, inflammation, and HIV persistence by the microbiome, short-chain fatty acids, and bile acids","volume":"10","author":"Enriquez","year":"2023","journal-title":"Annu Rev Virol"},{"key":"R20-20260810","doi-asserted-by":"crossref","first-page":"1244293","DOI":"10.3389\/fmicb.2023.1244293","article-title":"Gut commensals and their metabolites in health and disease","volume":"14","author":"Krishnamurthy","year":"2023","journal-title":"Front Microbiol"},{"key":"R21-20260810","doi-asserted-by":"crossref","first-page":"1332\u201345","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"R22-20260810","doi-asserted-by":"crossref","first-page":"2325\u201340","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"R23-20260810","doi-asserted-by":"crossref","first-page":"451\u201355","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"R24-20260810","doi-asserted-by":"crossref","first-page":"1\u201310","DOI":"10.1093\/toxsci\/kfae050","article-title":"Mechanisms underlying aryl hydrocarbon receptor-driven divergent macrophage function","volume":"200","author":"Malany","year":"2024","journal-title":"Toxicol Sci"},{"key":"R25-20260810","doi-asserted-by":"crossref","first-page":"123606","DOI":"10.1016\/j.lfs.2025.123606","article-title":"Targeting gut-immune-heart modulates cardiac remodeling after acute myocardial infarction","volume":"371","author":"Yu","year":"2025","journal-title":"Life Sci"},{"key":"R26-20260810","doi-asserted-by":"crossref","first-page":"765591","DOI":"10.3389\/fcvm.2021.765591","article-title":"Spermidine affects cardiac function in heart failure mice by influencing the gut microbiota and cardiac galectin-3","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R27-20260810","doi-asserted-by":"crossref","first-page":"175355","DOI":"10.1016\/j.ejphar.2022.175355","article-title":"Gut microbiota and myocardial fibrosis","volume":"940","author":"Xu","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R28-20260810","doi-asserted-by":"crossref","first-page":"2536\u201349","DOI":"10.1093\/cvr\/cvad116","article-title":"Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R29-20260810","first-page":"549\u201374","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2013","journal-title":"Cell Mol Life Sci CMLS"},{"key":"R30-20260810","doi-asserted-by":"crossref","first-page":"1183\u201396","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ Res"},{"key":"R31-20260810","doi-asserted-by":"crossref","first-page":"837509","DOI":"10.3389\/fphar.2021.837509","article-title":"Role of butyrate, a gut microbiota derived metabolite, in cardiovascular diseases: a comprehensive narrative review","volume":"12","author":"Amiri","year":"2022","journal-title":"Front Pharmacol"},{"key":"R32-20260810","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.3390\/molecules24213992","article-title":"Circulating metabolites originating from gut microbiota control endothelial cell function","volume":"24","author":"Amedei","year":"2019","journal-title":"Molecules"},{"key":"R33-20260810","doi-asserted-by":"crossref","first-page":"518\u201333","DOI":"10.1093\/eurheartj\/ehab644","article-title":"Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism","volume":"43","author":"Haghikia","year":"2022","journal-title":"Eur Heart J"},{"key":"R35-20260810","first-page":"2269\u201384","article-title":"Gut microbiota and microbiota-derived metabolites in cardiovascular diseases","volume":"136","author":"Chen","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R36-20260810","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/nu14132654","article-title":"Gut microbiota-derived metabolites and cardiovascular disease risk: a systematic review of prospective cohort studies","volume":"14","author":"S\u00e1nchez-Gim\u00e9nez","year":"2022","journal-title":"Nutrients"},{"key":"R37-20260810","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/biomedicines11082313","article-title":"Recent advances in microbiota-associated metabolites in heart failure","volume":"11","author":"Masenga","year":"2023","journal-title":"Biomedicines"},{"key":"R38-20260810","doi-asserted-by":"crossref","first-page":"102686","DOI":"10.1016\/j.cpcardiol.2024.102686","article-title":"Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease","volume":"49","author":"Safdar","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R39-20260810","first-page":"649\u201367","article-title":"The International scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R40-20260810","doi-asserted-by":"crossref","first-page":"105\u201314","DOI":"10.1016\/j.tifs.2018.03.009","article-title":"Postbiotics: an evolving term within the functional foods field","volume":"75","author":"Aguilar-Toal\u00e1","year":"2018","journal-title":"Trends Food Sci Technol"},{"key":"R41-20260810","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3390\/ijms20194673","article-title":"Postbiotics and their potential applications in early life nutrition and beyond","volume":"20","author":"Wegh","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R42-20260810","doi-asserted-by":"crossref","first-page":"101\u201307","DOI":"10.3920\/BM2012.0046","article-title":"Postbiotics: what else?","volume":"4","author":"Tsilingiri","year":"2013","journal-title":"Benef Microbes"},{"key":"R43-20260810","doi-asserted-by":"crossref","first-page":"261\u201374","DOI":"10.1007\/s12263-011-0218-x","article-title":"The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)","volume":"6","author":"Taverniti","year":"2011","journal-title":"Genes Nutr"},{"key":"R44-20260810","doi-asserted-by":"crossref","first-page":"1519\u201328","DOI":"10.3748\/wjg.v17.i12.1519","article-title":"Potential beneficial effects of butyrate in intestinal and extraintestinal diseases","volume":"17","author":"Canani","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R45-20260810","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01204","article-title":"Gut bifidobacteria populations in human health and aging","volume":"7","author":"Arboleya","year":"2016","journal-title":"Front Microbiol"},{"key":"R46-20260810","doi-asserted-by":"crossref","first-page":"171\u201381","DOI":"10.1038\/nrmicro.2017.149","article-title":"Microbial modulation of cardiovascular disease","volume":"16","author":"Brown","year":"2018","journal-title":"Nat Rev Microb"},{"key":"R47-20260810","doi-asserted-by":"crossref","first-page":"106920","DOI":"10.1016\/j.phrs.2023.106920","article-title":"Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats","volume":"196","author":"Mei","year":"2023","journal-title":"Pharmacol Res"},{"key":"R48-20260810","doi-asserted-by":"crossref","first-page":"2531198","DOI":"10.1080\/19490976.2025.2531198","article-title":"Programmable probiotic consortium employs an oleic acid-inducible system to sense and degrade cholesterol in high-fat diet mice","volume":"17","author":"Yang","year":"2025","journal-title":"Gut Microbes"},{"key":"R49-20260810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fcell.2017.00077","article-title":"Synthetic gene expression circuits for designing precision tools in oncology","volume":"5","author":"Re","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"R50-20260810","doi-asserted-by":"crossref","first-page":"1947\u201358","DOI":"10.4014\/jmb.2407.07004","article-title":"Synthetic biology-driven microbial therapeutics for disease treatment","volume":"34","author":"Kim","year":"2024","journal-title":"J Microbiol Biotechnol"},{"key":"R51-20260810","first-page":"5\u201316","article-title":"Synthetic biology and engineered live biotherapeutics: toward increasing system complexity","volume":"7","author":"Ozdemir","year":"2018","journal-title":"Cell Syst"},{"key":"R52-20260810","first-page":"82","article-title":"Nanoparticle based cardiac specific drug delivery","volume":"12","author":"Li","year":"2023","journal-title":"Biology (Basel)"},{"key":"R53-20260810","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FJC.0000000000000606","article-title":"Size-dependent ability of liposomes to accumulate in the ischemic myocardium and protect the heart","volume":"72","author":"Mukhamadiyarov","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"R54-20260810","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fbioe.2020.00687","article-title":"Nanoparticle-mediated drug delivery for treatment of ischemic heart disease","volume":"8","author":"Fan","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"R55-20260810","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/pharmaceutics14050930","article-title":"Nanocarrier-based targeted therapies for myocardial infarction","volume":"14","author":"George","year":"2022","journal-title":"Pharmaceutics"},{"key":"R56-20260810","doi-asserted-by":"crossref","first-page":"718674","DOI":"10.3389\/fcvm.2021.718674","article-title":"Oral supplementation with butyrate improves myocardial ischemia\/reperfusion injury via a gut-brain neural circuit","volume":"8","author":"Yu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R57-20260810","doi-asserted-by":"crossref","first-page":"123407","DOI":"10.1016\/j.lfs.2025.123407","article-title":"Butyrate increases cardiac output and causes vasorelaxation in a healthy porcine model","volume":"363","author":"Christensen","year":"2025","journal-title":"Life Sci"},{"key":"R59-20260810","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/biom12111640","article-title":"Postbiotics and their health modulatory biomolecules","volume":"12","author":"Scott","year":"2022","journal-title":"Biomolecules"},{"key":"R60-20260810","first-page":"100708","article-title":"Promising bioactivities of postbiotics: a comprehensive review","volume":"14","author":"Rafique","year":"2023","journal-title":"J Agric Food Res"},{"key":"R62-20260810","doi-asserted-by":"crossref","first-page":"221\u201328","DOI":"10.2174\/0115748871279354240209101604","article-title":"Evaluation of Urolithin A efficacy in heart failure patients with reduced ejection fraction: a randomized, double-blind, crossover, placebo-controlled clinical trial","volume":"19","author":"Jamialahmadi","year":"2024","journal-title":"Rev Recent Clin Trials"},{"key":"R63-20260810","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R65-20260810","doi-asserted-by":"crossref","first-page":"101772","DOI":"10.1016\/j.redox.2020.101772","article-title":"Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics","volume":"38","author":"Paul","year":"2021","journal-title":"Redox Biol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:03:47Z","timestamp":1786359827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004529","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"2025-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}